News
Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.
Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...
Experts have shared their thoughts on the impacts that GLP-1 medications such as Ozempic can have on libido as a side effect ...
Historically, managing type 2 diabetes in advanced chronic kidney disease (CKD) has been challenging due to a lack of therapies and increased risks for adverse events.
GLP-1 RAs are associated with a modestly increased risk for GERD and gallstone disease but not with GI and biliary complications.
Here’s a roundup of numbers from the last week of HR news — including the percentage of managers who use AI to help determine ...
A study published in the Journal of Medical Toxicology by researchers at the University of Alabama at Birmingham found that ...
The expert has revealed why the GLP-1 medication could be playing a role in the bedroom and paving the way for divorce in ...
2d
Discover Magazine on MSNOzempic and Other GLP-1 Side Effects May Outweigh the BenefitsGlucagon-like peptide-1 receptor agonists (GLP-1RA) drugs, such as Ozempic and Wegovy, are often referred to as "miracle ...
A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results